approval · primary record
CLINDAMYCIN PHOSPHATE
3 approval events · latest 2026-03-26
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Latest action | 2026-03-26 |
| Approval events | 3 |
| Brand | CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER |
| Sponsor | PFIZER |
| Route | INJECTION |
Approval history
3 actions on record. The drug is the stable record; each action below is an event with its own date, so this URL keeps working as new actions arrive.
| Date | Agency | Type | Brand | Sponsor | Route |
|---|---|---|---|---|---|
| 2026-03-26 | FDA | NDA | CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER | PFIZER | INJECTION |
| 2025-11-12 | FDA | NDA | CLEOCIN T | PFIZER | TOPICAL |
| 2025-01-30 | FDA | NDA | CLINDESSE | PADAGIS US | VAGINAL |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-30T00:29:38.390Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: approval:clindamycin-phosphate
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Clindamycin Phosphate · compound